Cargando…

Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome

INTRODUCTION: Minimal residual disease (MRD) remaining after curative therapy for prostate cancer has the potential for growth and can result in metastasis. Circulating prostate cells (CPCs) and bone marrow micro-metastasis (mM) could represent different types of MRD. We here determined; biochemical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Salazar, Anibal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844623/ https://www.ncbi.nlm.nih.gov/pubmed/29374406 http://dx.doi.org/10.22034/APJCP.2018.19.1.229

Ejemplares similares

The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2020)

Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
por: Murray, Nigel P, et al.
Publicado: (2016)

Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2019)

10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2018)

Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2018)

Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2022)

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2018)

The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2020)

The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
por: Murray, Nigel P, et al.
Publicado: (2017)

Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
por: Murray, Nigel P., et al.
Publicado: (2013)

Renal infarction associated with asymptomatic Covid-19 infection
por: Murray, Nigel P, et al.
Publicado: (2021)

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
por: Murray, Nigel P, et al.
Publicado: (2019)

Primary Circulating Prostate Cells Are Not Detected in Men with Low Grade Small Volume Prostate Cancer
por: Murray, Nigel P., et al.
Publicado: (2014)

Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
por: Murray, Nigel P.
Publicado: (2018)

Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications
por: Murray, Nigel P., et al.
Publicado: (2013)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone
por: Murray, Nigel P, et al.
Publicado: (2020)

Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy
por: Mazzucchelli, Roberta, et al.
Publicado: (2007)

Salvage surgery for residual disease following unsuccessful laparoscopic radical prostatectomy for prostate cancer
por: Tashiro, Kojiro, et al.
Publicado: (2020)

Anatomic Considerations for Radical Retropubic Prostatectomy in an Achondroplastic Dwarf
por: Gyomber, Dennis, et al.
Publicado: (2009)

Differential Expression of Matrix Metalloproteinase-2 Expression in Disseminated Tumor Cells and Micrometastasis in Bone Marrow of Patients with Nonmetastatic and Metastatic Prostate Cancer: Theoretical Considerations and Clinical Implications—An Immunocytochemical Study
por: Murray, Nigel P., et al.
Publicado: (2012)

Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome
por: Murray, Nigel P, et al.
Publicado: (2022)

Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature
por: Murray, Nigel P., et al.
Publicado: (2018)

Outcomes of prostate cancer patients after robot-assisted radical prostatectomy compared with open radical prostatectomy in Korea
por: Jung, Jaehun, et al.
Publicado: (2023)

Radical Prostatectomy: An Option for High-Risk Prostate Cancer
por: Rausch, S., et al.
Publicado: (2012)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

The role of radical prostatectomy in high-risk prostate cancer
por: Chung, Byung Ha
Publicado: (2013)

A Case of Prostatectomy for the Radical Cure of Prostatic Stone
por: Powell, Arthur
Publicado: (1898)

Functional recovery after radical prostatectomy for prostate cancer
por: Ko, Young Hwii
Publicado: (2018)

Radical prostatectomy for high-risk prostate cancer | Opinion: NO
por: Ghodoussipour, Saum, et al.
Publicado: (2019)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
por: Lee, Dan Bee, et al.
Publicado: (2023)

Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
por: Murray, Nigel P, et al.
Publicado: (2019)

Robotic Radical Prostatectomy in Patients with Previous Prostate Surgery and Radiotherapy
por: Acar, Ömer, et al.
Publicado: (2014)

Current Status of Radical Prostatectomy for High-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2014)

Interpositional Nerve Grafting of the Prostatic Plexus after Radical Prostatectomy
por: Kung, Theodore A., et al.
Publicado: (2015)

Robot-Assisted Radical Prostatectomy After Previous Prostate Surgery
por: Tugcu, Volkan, et al.
Publicado: (2015)

Recurrence of Prostate Cancer with Cutaneous Metastasis after Radical Prostatectomy
por: Patel, Parth, et al.
Publicado: (2015)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No
por: Ristau, Benjamin T., et al.
Publicado: (2016)

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
por: Reis, Leonardo O., et al.
Publicado: (2019)

Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
por: Axcrona, Karol, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gmfo85rkooomc14p2s2pilrlhb